Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies. [electronic resource]
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Oct 2016
- 155-164 p. digital
Publication Type: Journal Article
1873-376X
10.1016/j.jchromb.2016.05.045 doi
Antineoplastic Agents--chemistry Bevacizumab--chemistry Cetuximab--chemistry Drug Stability Enzyme-Linked Immunosorbent Assay--methods Humans Protein Stability Trastuzumab--chemistry